Publications by authors named "Chinbayar Tserendorj"

Background: Hepatocellular carcinoma (HCC) is the most common cancer in Mongolia. The relative importance of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in HCC etiology is known to vary greatly from one part of the world to another. Principally, 95% of HCC patients have chronic viral hepatitis, including 53% hepatitis B virus, 38.

View Article and Find Full Text PDF

We aimed to determine potential risk factors for COVID-19 severity including serum vitamin D levels and latent TB infection among Mongolian inpatients diagnosed with COVID-19, and to study the effects of disease complications and treatment outcomes. This study included patients admitted to the Mongolian National Center for Communicable Disease, a main referral center for infectious disease in Mongolia, with COVID-19 ascertained by a positive PCR test. Patients' demographic, clinical, and laboratory data were analyzed.

View Article and Find Full Text PDF

Background: A nationwide vaccination program against coronavirus disease 2019 (COVID-19) was started in Mongolia 4 months after the first local transmission, which occurred in November 2020. Previous studies have reported that two doses of COVID-19 vaccine result in increased antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A study was conducted in Mongolia 2 weeks after the second vaccine dose.

View Article and Find Full Text PDF

Introduction: The study was focused on comparing crude and sex-adjusted hazard ratio calculated by the baseline variables which may have contributed to the severity of the disease course and fatal outcomes in Coronavirus Disease-19 (COVID-19) patients.

Method: The study enrolled 150 eligible adult patients with confirmed SARS-CoV-2 infection. There were 61 (40.

View Article and Find Full Text PDF

Background And Aims: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns of SARS-Cov-2 in CLD patients, with or without cirrhosis.

View Article and Find Full Text PDF
Article Synopsis
  • - A study examined how neuraminidase inhibitors (NAIs) affect the length of hospital stays for patients with influenza A(H1N1)pdm09 by analyzing data from over 18,000 individuals from 70 clinical centers.
  • - Results indicated that starting NAI treatment upon hospitalization leads to a 19% decrease in length of stay compared to starting later or not at all, with consistent findings across different patient groups.
  • - The study concluded that immediate NAI treatment for hospitalized influenza patients correlates with shorter hospital stays compared to delayed treatment or no treatment, regardless of when symptoms began.
View Article and Find Full Text PDF

Background: Surveillance data from a large measles outbreak in Mongolia suggested increased case fatality ratio (CFR) in the second of 2 waves. To confirm the increase in CFR and identify risk factors for measles death, we enhanced mortality ascertainment and conducted a case-control study among infants hospitalized for measles.

Methods: We linked national vital records with surveillance data of clinically or laboratory-confirmed infant (aged <12 months) measles cases with rash onset during March-September 2015 (wave 1) and October 2015-June 2016 (wave 2).

View Article and Find Full Text PDF